Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04526106 |
|---|---|
| Brief Title: | REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors |
| First Submitted : | August 7, 2020 |
| First Submitted that Met QC Criteria : | August 20, 2020 |
| First Posted : | August 25, 2020 |
| Last Update Submitted that Met QC Criteria : | March 1, 2024 |
| Last Update Posted : | March 5, 2024 |